GRTS logo

Gritstone bio (GRTS)

Profile

Full Name

Gritstone bio, Inc.

Ticker Symbol

GRTS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 28, 2018

Indexes

Not included

Website

http://gritstonebio.com

Employees

231

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.33M(-85.64% YoY)

Annual EPS

-$1.20(+9.09% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

-
GRTS price value is unknown

30-Day Relative Volume

-
GRTS 30-day relative volume value is unknown

Price Performance

Price Most recent change

-
GRTS price change on Jan 1, 1 is unknown

Price YTD change

-
GRTS price ytd change is unknown

Price 1-year change

-
GRTS price 1-year change is unknown

Price 3-year change

-
GRTS price 3-year change is unknown

Price Range

Price All-time high

$35.20
GRTS price is currently at an all-time high

Price 3-year low

$0.00
GRTS price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
GRTS market capitalization value is unknown

Market cap 3-year change

-
GRTS market capitalization 3-year change is unknown

Market cap All-time high

$1.29B
GRTS market capitalization is currently at an all-time high

Market cap sector rank

-
GRTS market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

+10.25%
GRTS shares outstanding is up +10.25% year-on-year

Shares Outstanding 3-Year Change

+62.21%
GRTS shares outstanding is up +62.21% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
GRTS beta value is unknown

200-day SMA

-
GRTS SMA 200 is unknown

50-day SMA

-
GRTS SMA 50 is unknown

RSI

-
GRTS 14-day relative strength index value is unknown

Volume

-
GRTS 30-day relative volume value is unknown

ATR

-
GRTS average true range value is unknown

10-day Historical Volatility

-
GRTS 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.33M
GRTS annual revenue is $1.33 million

Revenue Analysts estimate

$2.85M
GRTS annual revenue is currently -53.30% lower than the consensus analysts' forecast

Revenue 1-year change

-85.64%
GRTS annual revenue is down -85.64% year-on-year

Revenue Sector rank

-
GRTS annual revenue is unknown

EPS

EPS

-$1.20
GRTS annual earnings per share is -$1.20

EPS Analysts estimate

-$0.95
GRTS annual earnings per share is currently +26.32% higher than the consensus analysts' forecast

EPS 1-year change

+9.09%
GRTS annual earnings per share is up +9.09% year-on-year

EPS Sector rank

-
GRTS annual earnings per share is unknown

Profit

Gross profit

-
GRTS annual gross profit value is unknown

Gross margin

-
GRTS annual gross profit margin value is unknown

Operating profit

-$139.62M
GRTS annual operating income is -$139.62 million

Operating margin

-10.49K%
GRTS annual operating profit margin is -10.49 thousand%

Net income

-$138.49M
GRTS annual net profit is -$138.49 million

Net margin

-10.40K%
GRTS annual net profit margin is -10.40 thousand%

Expenses

Total expenses

$140.95M
GRTS annual total expenses is $140.95 million

Operating expenses

$140.95M
GRTS annual total operating expenses is $140.95 million

Cost of goods sold

-
GRTS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$28.78M
GRTS annual SGA is $28.78 million

Depreciation and amortization

$7.59M
GRTS annual depreciation & amortization is $7.59 million

Interest expense

$4.04M
GRTS annual interest expense is $4.04 million

Income tax

-
GRTS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$134.45M
GRTS annual earnings before interest & taxes is -$134.45 million

EBITDA

-$126.86M
GRTS annual EBITDA is -$126.86 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$177.77M
GRTS annual total assets is $177.77 million

Non current assets

$90.33M
GRTS annual long term assets is $90.33 million

Current assets

$87.44M
GRTS annual total current assets is $87.44 million

Cash and cash equivalents

$62.99M
GRTS annual cash & cash equivalents is $62.99 million

Accounts receivable

-
GRTS annual accounts receivable value is unknown

Inventory

-
GRTS annual inventory value is unknown

Liabilities

Total liabilities

$125.92M
GRTS annual total liabilities is $125.92 million

Long term liabilities

$98.58M
GRTS annual total long term liabilities is $98.58 million

Current liabilities

$27.34M
GRTS annual total current liabilities is $27.34 million

Accounts payable

$3.82M
GRTS annual accounts payable is $3.82 million

Debt

Total debt

$104.78M
GRTS annual total debt is $104.78 million

Total debt 1-year change

+159.88%
GRTS annual total debt is up +159.88% year-on-year

Long term debt

$97.87M
GRTS annual long term debt is $97.87 million

Short term debt

$6.90M
GRTS annual short term debt is $6.90 million

Equity & Capital

Shareholders equity

$51.85M
GRTS annual stockholders equity is $51.85 million

Book value

$51.85M
GRTS annual book value is $51.85 million

Retained earnings

-$659.56M
GRTS annual retained earnings is -$659.56 million

Working capital

$60.10M
GRTS annual working capital is $60.10 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$121.65M
GRTS annual cash flow from operations is -$121.65 million

Cash from operations 1-year change

-4.92%
GRTS annual cash flow from operations is down -4.92% year-on-year

Cash from investing

$102.34M
GRTS annual cash flow from investing activities is $102.34 million

Cash from investing 1-year change

+889.42%
GRTS annual cash flow from investing activities is up +889.42% year-on-year

Cash from financing

$25.12M
GRTS annual cash flow from financing activities is $25.12 million

Cash from financing 1-year change

-69.77%
GRTS annual cash flow from financing activities is down -69.77% year-on-year

CAPEX

CAPEX

$4.57M
GRTS annual capital expenditures is $4.57 million

CAPEX 1-year change

-22.14%
GRTS annual capital expenditures is down -22.14% year-on-year

Free Cash Flow

Free cash flow

-$126.22M
GRTS annual free cash flow is -$126.22 million

Free cash flow 1-year change

-3.61%
GRTS annual free cash flow is down -3.61% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GRTS annual gross profit margin value is unknown

Operating margin

-10.49K%
GRTS annual operating profit margin is -10.49 thousand%

Net margin

-10.40K%
GRTS annual net profit margin is -10.40 thousand%

ROA & ROE

ROA

-66.18%
GRTS annual return on assets is -66.18%

ROE

-124.41%
GRTS annual return on equity is -124.41%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GRTS price to earnings ratio value is unknown

PE ratio Sector rank

-
GRTS price to earnings ratio is unknown

PB Ratio

PB ratio

-
GRTS price to book ratio value is unknown

PB ratio Sector rank

-
GRTS price to book ratio is unknown

PS Ratio

PS ratio

-
GRTS price to sales ratio value is unknown

PS ratio Sector rank

-
GRTS price to sales ratio is unknown

Enterprise value

Enterprise value

-
GRTS enterprise value value is unknown

Enterprise value Sector rank

-
GRTS enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
GRTS EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
GRTS EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.20
GRTS annual current ratio is 3.20

Quick ratio

-
GRTS annual quick ratio value is unknown

Leverage

Debt to equity

0.77
GRTS annual debt to equity ratio is 0.77

Interest coverage ratio

-33.31
GRTS annual interest coverage ratio is -33.31

Risk & Stability

Piotroski F-Score

-
GRTS piotroski f-score value is unknown

Altman Z-Score

-
GRTS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Oct 2, 24 Jones Trading
Hold
Oct 2, 24 B. Riley Securities
Neutral
Oct 1, 24 JMP Securities
Market Perform
Oct 1, 24 HC Wainwright & Co.
Neutral
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 5, 24 JMP Securities
Market Outperform
Aug 5, 24 HC Wainwright & Co.
Buy
Jun 14, 24 JMP Securities
Market Outperform
May 24, 24 B. Riley Securities
Buy
May 13, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Gritstone bio?
  • Does Gritstone bio pay dividends?
  • What sector is Gritstone bio in?
  • What industry is Gritstone bio in?
  • What country is Gritstone bio based in?
  • When did Gritstone bio go public?
  • Is Gritstone bio in the S&P 500?
  • Is Gritstone bio in the NASDAQ 100?
  • Is Gritstone bio in the Dow Jones?
  • When was Gritstone bio's last earnings report?
  • When does Gritstone bio report earnings?
  • Should I buy Gritstone bio stock now?

What is the ticker symbol for Gritstone bio?

The ticker symbol for Gritstone bio is NASDAQ:GRTS

Does Gritstone bio pay dividends?

No, Gritstone bio does not pay dividends

What sector is Gritstone bio in?

Gritstone bio is in the Healthcare sector

What industry is Gritstone bio in?

Gritstone bio is in the Biotechnology industry

What country is Gritstone bio based in?

Gritstone bio is headquartered in United States

When did Gritstone bio go public?

Gritstone bio's initial public offering (IPO) was on September 28, 2018

Is Gritstone bio in the S&P 500?

No, Gritstone bio is not included in the S&P 500 index

Is Gritstone bio in the NASDAQ 100?

No, Gritstone bio is not included in the NASDAQ 100 index

Is Gritstone bio in the Dow Jones?

No, Gritstone bio is not included in the Dow Jones index

When was Gritstone bio's last earnings report?

Gritstone bio's most recent earnings report was on Nov 8, 2024

When does Gritstone bio report earnings?

The date for Gritstone bio's next earnings report has not been announced yet

Should I buy Gritstone bio stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page